US 11911484
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
granted A61KA61K47/60A61K47/6807
Quick answer
US patent 11911484 (Muscle targeting complexes and uses thereof for treating myotonic dystrophy) held by Dyne Therapeutics, Inc. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K47/60, A61K47/6807, A61K47/6849, A61K47/6889